Published on : Aug 23, 2016
ALBANY, New York, August 23, 2016: A new market intelligence study has recently been added by ResearchMoz.us to its vast collection of research reports. The 246-page research study, titled “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia,” offers a detailed analysis of the market, focusing on the regulatory norms and reimbursement strategies in this region. To give a clear picture of the market, the research study has included historical information and forecast statistics of the healthcare market in Saudi Arabia with the help of charts, tables, and infographics.
The research report takes the help of several analysis tools to determine and identify the current trends in the healthcare market in Saudi Arabia. The study further presents insights into the regulatory, demographic, and reimbursement scenario, and the healthcare infrastructure in Saudi Arabia. The recommendations added in the research study are projected to guide the leading players in designing effective business policies in the next few years.
As per the research study, in 2012, around 32.1% of the overall population of Saudi Arabia was non-native. Most of them were immigrant workers and laborers from South Asian countries and other Muslim countries. In 2013, the population of Saudi Arabia was around 29.9 mn; this is estimated to reach around 36.8 mn by the end of 2020. The growing population and the rising incidence of various disorders and diseases are the key factors accelerating the growth of the healthcare market in Saudi Arabia.
Click here to get more info with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=210565
Furthermore, in 2013, the Saudi Arabia market for pharmaceuticals was worth US$4 bn and is anticipated to exhibit a healthy 5.80% CAGR between 2014 and 2020. The market is predicted to reach a value of US$5.9 bn by the end of 2020. The rapid growth of this market in Saudi Arabia can be attributed to the growing imports of patented products and over-the-counter drugs.
The rising government initiatives regarding the management and prevention of chronic diseases are one of the key factors estimated to augment the growth of the healthcare market in Saudi Arabia. In addition, the improved healthcare infrastructure and updated regulatory environment are expected to contribute extensively towards the development of the overall market in the next few years. The prominent players in the healthcare market in Saudi Arabia are focusing on providing enhanced products and services to the patients by providing favorable reimbursement policies. This trend is estimated to accelerate the growth of the overall market throughout the forecast period.
The research report further analyzes the key players active in the healthcare market in Saudi Arabia and throws light on the vendor analysis of the market. Some of the leading players included in the research report are SPIMACO, F. Hoffmann-La Roche, Siemens Healthcare, Novartis, Tabuk, GlaxoSmithKline, Pfizer, Abbott Laboratories, Philips Healthcare, and GE Healthcare. Detailed profiles of these players have been discussed in the research study to give a clear understanding of the market.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on [email protected]